Genpharmasec Limited has formally declared to BSE Limited that it does not fall under the Large Corporate (LC) framework as specified in SEBI regulations. The declaration was made on April 14, 2026, providing clarity on the company's regulatory compliance status.

SEBI Circular Compliance Declaration

The company's declaration specifically references two key SEBI circulars that govern Large Corporate regulations:

These circulars establish the framework for fund raising through debt securities issuance by entities classified as Large Corporates and mandate specific disclosure requirements for such companies.

Company's Regulatory Status

Genpharmasec Limited has clearly stated that it does not meet the criteria to be classified as a Large Corporate under the SEBI framework. This determination has significant implications for the company's regulatory obligations and compliance requirements.

The declaration was signed by Mr. Sohan Chaturvedi, Whole Time Director and CFO (DIN: 09629728), and submitted to BSE Limited's Compliance Department of Corporate Services. The company operates from its registered office at 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Society Limited, Akurli Road, Kandivali (East), Mumbai 400101.

Compliance Implications

By confirming its non-Large Corporate status, Genpharmasec Limited is exempt from the disclosure obligations typically required under the referenced SEBI circulars. This exemption relieves the company from filing specific disclosures related to debt securities issuance frameworks applicable to Large Corporates.

The formal declaration ensures transparency with regulatory authorities and provides stakeholders with clear information about the company's compliance status under current SEBI regulations governing corporate debt fundraising activities.

Genpharmasec Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company submitted the mandatory certificate under Regulation 74(5) of SEBI regulations on April 8, 2026. The filing was signed by Mr. Sohan Chaturvedi, Whole Time Director and CFO (DIN: 09629728), and submitted to BSE Limited's Compliance Department.

Certificate Confirmation

The certificate was issued by Satellite Corporate Services Pvt. Ltd, the company's Registrar and Share Transfer Agent (RTA). According to the RTA's confirmation dated April 6, 2026, no physical share certificates were received for dematerialization during the quarter ended March 31, 2026.

The RTA, which holds Registration No. INR000003639 as a Category-I Registrar to an Issue & Share Transfer Agent, confirmed compliance with standard verification procedures. The certificate states that in cases where physical certificates are received, they undergo due verification, mutilation, and cancellation, with the depository's name being substituted as the registered owner.

Regulatory Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 requires companies to submit quarterly certificates regarding physical share certificates received for dematerialization. This regulation ensures transparency in the dematerialization process and maintains accurate records of securities transactions.

The filing demonstrates Genpharmasec Limited's commitment to regulatory compliance and transparent reporting practices. The company maintains its registered office at 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc Ltd., Akurli Road, Kandivali (East), Mumbai 400101.